featured
Fenofibrate and Risk of End-Stage Renal Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fenofibrate and risk of end-stage renal disease: A nationwide cohort study
Diabetes Obes Metab 2024 Jul 29;[EPub Ahead of Print], YY Hyun, KS Kim, S Hong, K Han, CY ParkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.